English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  52565024    Online Users :  667
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

Jump to: [ Chinese Items ] [ 0-9 ] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
or enter the first few letters:   

Showing items 346016-346040 of 2348609  (93945 Page(s) Totally)
<< < 13836 13837 13838 13839 13840 13841 13842 13843 13844 13845 > >>
View [10|25|50] records per page

Institution Date Title Author
國立臺灣大學 2001 Duration of Enterovirus Shedding in Stool 張鑾英; CHANG, LUAN-YIN
國立臺灣大學 2001 Duration of enterovirus shedding in stool Chung, PW; Huang, YC; Chang, LY; Lin, TY
國立臺灣大學 1993 Duration of magnetic aftereffect Klik, Ivo; Chang, Ching-Ray
臺大學術典藏 2019-12-20T01:17:45Z Duration of Magnetic Aftereffect Klik, I.;Chang, Cr; Klik, I.; Chang, Cr; CHING-RAY CHANG
臺大學術典藏 2018-09-10T08:39:55Z Durational patterning at syntactic and discourse boundaries in Mandarin spontaneous speech Yee-Jean Fon; YEE-JEAN FON; YEE-JEAN FON
國立臺灣師範大學 2014-10-27T15:15:02Z Durative Complements in the Hakka Verb Copying Construction 葉瑞娟; Jui-chuan Yeh
國立政治大學 2008 Durative Event: A Comparison of gan3 and qiang3 鍾曉芳
淡江大學 2008 Durbin方法於彈壓電複合層板動力破壞分析之應用 應宜雄; 許吉勝
臺大學術典藏 2008 Durumolides A–E, anti-inflammatory and antibacterial cembranolides from the soft coral Lobophytum durum Duh, Chang-Yih; Chiang, Michael Y.; Dai, Chang-Feng; Wang, Shang-Kewi; Cheng, Shi-Yie; Wen, Zhi-Hong; Chiou, Shu-Fen; Hsu, Chi-Hsin; Wang, Shang-Kewi; Dai, Chang-Feng; Chiang, Michael Y.; Duh, Chang-Yih; Cheng, Shi-Yie; Wen, Zhi-Hong; Chiou, Shu-Fen; Hsu, Chi-Hsin
國立臺灣大學 2008 Durumolides A–E, anti-inflammatory and antibacterial cembranolides from the soft coral Lobophytum durum Cheng, Shi-Yie; Wen, Zhi-Hong; Chiou, Shu-Fen; Hsu, Chi-Hsin; Wang, Shang-Kewi; Dai, Chang-Feng; Chiang, Michael Y.; Duh, Chang-Yih
臺大學術典藏 2020-05-26T09:26:29Z Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study Havel L; Pauk N; Singh J; Murakami S; Garassino M.C; Cho B.-C; Kim J.-H; Mazières J; Vansteenkiste J; Lena H; Corral Jaime J; Gray J.E; Powderly J; Chouaid C; Bidoli P; Wheatley-Price P; Park K; Soo R.A; Huang Y; Wadsworth C; Dennis P.A; Rizvi N.A; Paz-Ares Rodriguez L; Novello S; Hiret S; Schmid P; Laack E; Califano R; Maemondo M; Kim S.-W; Chaft J; Vicente Baz D; Berghmans T; Kim D.-W; Surmont V; Reck M; Han J.-Y; Holgado Martin E; Belda Iniesta C; Oe Y; Chella A; Chopra A; Robinet G; Soto Parra H; Thomas M; Cheema P; Katakami N; Su W.-C; Kim Y.-C; Wolf J; Lee J.-S; Saka H; Milella M; Ramos Garcia I; Sibille A; Yokoi T; Kang E.J; Atagi S; Spaeth-Schwalbe E; Nishio M; Imamura F; Gabrail N; Veillon R; Derijcke S; Maeda T; Zylla D; Kubiak K; Santoro A; Uy M.N; Lucien Geater S; Italiano A; Kowalski D; Barlesi F; Chen Y.-M; Spigel D; Chewaskulyong B; Garcia Gomez R; Alvarez Alvarez R; CHIH-HSIN YANG; Hsia T.-C; Denis F; Sakai H; Vincent M; Goto K; Bosch-Barrera J; Weiss G; Canon J.-L; Scholz C; Aglietta M; Kemmotsu H; Csoszi T; Losonczy G; Price A; Anderson I; Iqbal M; Torri V; Juhasz E; Khanani S; Koubkova L; Levy B; Page R; Bocskei C; Crinò L; Einspahr D; Hagenstad C; Juat N; Overton L; Garrison M; Szalai Z; ATLANTIC Investigators; Azuma K; Bradbury P; Feld R; Chachoua A; Jassem J; Juergens R; Palmero Sanchez R; Malcolm A; Vrindavanam N; Kubota K; Waller C; Waterhouse D; Coudert B; Mark Z; Satouchi M; Chang G.-C; Herzmann C; Chaudhry A; Giridharan S; Hesketh P; Ikeda N; Boccia R; Iannotti N; Haigentz M; Reynolds J; Querol J; Nakagawa K; Sugawara S; Tan E.H; Hirashima T; Gettinger S; Kato T; Takeda K; Juan Vidal O; Mohn-Staudner A; Panwalkar A; Daniel D; Kobayashi K; Ladrera G.E.I; Schulte C; Sebastian M; Cernovska M; Coupkova H; Juat N;Hagenstad C;Einspahr D;Crin? L;Bocskei C;Page R;Levy B;Koubkova L;Khanani S;Juhasz E;Torri V;Iqbal M;Anderson I;Price A;Losonczy G;Csoszi T;Murakami S;Singh J;Pauk N;Havel L;Coupkova H;Cernovska M;Sebastian M;Schulte C;Ladrera G.E.I;Kobayashi K;Daniel D;Panwalkar A;Mohn-Staudner A;Juan Vidal O;Takeda K;Kato T;Gettinger S;Hirashima T;Tan E.H;Sugawara S;Nakagawa K;Querol J;Reynolds J;Haigentz M;Iannotti N;Boccia R;Ikeda N;Hesketh P;Giridharan S;Chaudhry A;Herzmann C;Chang G.-C;Satouchi M;Mark Z;Coudert B;Waterhouse D;Waller C;Kubota K;Vrindavanam N;Malcolm A;Palmero Sanchez R;Juergens R;Jassem J;Chachoua A;Feld R;Bradbury P;Azuma K;Kemmotsu H;Aglietta M;Scholz C;Canon J.-L;Weiss G;Bosch-Barrera J;Goto K;Vincent M;Sakai H;Denis F;Hsia T.-C;Chih-Hsin Yang;Alvarez Alvarez R;Garcia Gomez R;Chewaskulyong B;Spigel D;Chen Y.-M;Barlesi F;Kowalski D;Italiano A;Lucien Geater S;Uy M.N;Santoro A;Kubiak K;Zylla D;Maeda T;Derijcke S;Veillon R;Gabrail N;Imamura F;Nishio M;Spaeth-Schwalbe E;Atagi S;Kang E.J;Yokoi T;Sibille A;Ramos Garcia I;Milella M;Saka H;Lee J.-S;Wolf J;Kim Y.-C;Su W.-C;Katakami N;Atlantic Investigators;Szalai Z;Garrison M;Overton L;Cheema P;Thomas M;Soto Parra H;Robinet G;Chopra A;Chella A;Oe Y;Belda Iniesta C;Holgado Martin E;Han J.-Y;Reck M;Surmont V;Kim D.-W;Berghmans T;Vicente Baz D;Chaft J;Kim S.-W;Maemondo M;Califano R;Laack E;Schmid P;Hiret S;Novello S;Paz-Ares Rodriguez L;Rizvi N.A;Dennis P.A;Wadsworth C;Huang Y;Soo R.A;Park K;Wheatley-Price P;Bidoli P;Chouaid C;Powderly J;Gray J.E;Corral Jaime J;Lena H;Vansteenkiste J;Mazi?res J;Kim J.-H;Cho B.-C;Garassino M.C
國立成功大學 2024-08 Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1) : updated overall survival from a randomised phase 3 study Oh;Do-Youn;He;Ruth, Aiwu;Bouattour;Mohamed;Okusaka;Takuji;Qin;Shukui;Chen;Li-Tzong;Kitano;Masayuki;Lee;Choong-kun;Kim;Won, Jin;Chen;-Huang, Ming;Suksombooncharoen;Thatthan;Ikeda;Masafumi;Lee;Ah, Myung;Chen;Jen-Shi;Potemski;Piotr;Burris;Howard, A.;Ostwal;Vikas;Tanasanvimon;Suebpong;Morizane;Chigusa;Zaucha;Renata, E.;Mcnamara;Mairead, G.;Avallone;Antonio;Cundom;Juan, E.;Breder;Valeriy;Tan;Benjamin;Shimizu;Satoshi;Tougeron;David;Evesque;Ludovic;Petrova;Mila;Zhen;David, B.;Gillmore;Roopinder;Gupta;Govinda, Vineet;Dayyani;Farshid;Park;Oh, Joon;Jr, Buchschacher;Gary, L.;Rey;Felipe;Kim;Hyosung;Wang;Julie;Morgan;Claire;Rokutanda;Nana;Zotkiewicz;Magdalena;Vogel;Arndt;Valle;Juan, W.
國家衛生研究院 2024-08 Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): Updated overall survival from a randomised phase 3 study Oh, DY;He, AR;Bouattour, M;Okusaka, T;Qin, S;Chen, LT;Kitano, M;Lee, CK;Kim, JW;Chen, MH;Suksombooncharoen, T;Ikeda, M;Lee, MA;Chen, JS;Potemski, P;Burris, HA, 3rd;Ostwal, V;Tanasanvimon, S;Morizane, C;Zaucha, RE;McNamara, MG;Avallone, A;Cundom, JE;Breder, V;Tan, B;Shimizu, S;Tougeron, D;Evesque, L;Petrova, M;Zhen, DB;Gillmore, R;Gupta, VG;Dayyani, F;Park, JO;Buchschacher, GL, Jr.;Rey, F;Kim, H;Wang, J;Morgan, C;Rokutanda, N;Żotkiewicz, M;Vogel, A;Valle, JW
國立成功大學 2024 Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study Oh;D, -Y.;He;A, R.;Bouattour;M;Okusaka;T;Qin;S;Chen;L, -T.;Kitano;M;Lee;C, -K.;Kim;J, W.;Chen;M, -H.;Suksombooncharoen;T;Ikeda;M;Lee;M, -A.;Chen;J, -S.;Potemski;P;Burris;H, A.;Ostwal;V;Tanasanvimon;S;Morizane;C;Zaucha;R, E.;McNamara;M, G.;Avallone;A;Cundom;J, E.;Breder;V;Tan;B;Shimizu;S;Tougeron;D;Evesque;L;Petrova;M;Zhen;D, B.;Gillmore;R;Gupta;V, G.;Dayyani;F;Park;J, O.;Buchschacher;G, L.;Rey;F;Kim;H;Wang;J;Morgan;C;Rokutanda;N;Żotkiewicz;M;Vogel;A;Valle;J, W.
國家衛生研究院 2025-05-15 Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study Oh, DY;He, AR;Qin, S;Chen, LT;Okusaka, T;Kim, JW;Suksombooncharoen, T;Lee, MA;Kitano, M;Burris, HA;Bouattour, M;Tanasanvimon, S;Zaucha, R;Avallone, A;Cundom, J;Kuzko, A;Wang, J;Xynos, I;Vogel, A;Valle, JW
國家衛生研究院 2025-02 Durvalumab, tremelimumab, and platinum chemotherapy in EGFR mutation–positive NSCLC: An open-label Phase 2 trial (ILLUMINATE) Lee, CK;Liao, BC;Subramaniam, S;Chiu, CH;Mersiades, AJ;Ho, CC;Brown, C;Lai, CL;Hughes, BGM;Yang, TY;O'Byrne, K;Luo, YH;Yip, S;Ho, CL;Bray, V;Su, WC;Moore, M;Feng, WL;Bai, YY;Ford, K;Cummins, MM;Stockler, MR;Solomon, BJ;John, T;Chih-Hsin Yang, J
國立臺灣大學 1993 Dusformone and Dischidiol from Dischida Formosana Chen, Z. S.; Lee, G. H.; 郭悅雄; Chen, Z. S.; Lee, G. H.; Kuo, Yueh-Hsiung
國立成功大學 2013-08-27 dusfusion 在邊境細胞的功能分析 吳榛惟; Wu, Jhen-Wei
國立成功大學 2013-07-19 dusfusion 在邊境細胞的功能分析 吳榛惟; Wu, Jhen-Wei
國立臺灣大學 2015 DUSP1 Expression Induced by HDAC1 Inhibition Mediates Gefitinib Sensitivity in Non-Small Cell Lung Cancers Lin, Yun-Chieh; Lin, Yu-Chin; Shih, Jin-Yuan; Huang, Wei-Jan; Chao, Shi-Wei; Chang, Yih-Leong; Chen, Ching-Chow; 張逸良; 施金元; 陳青周
臺大學術典藏 2018-09-10T15:17:53Z DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers Lin, Yun-Chieh;Lin, Yu-Chin;Shih, Jin-Yuan;Huang, Wei-Jan;Chao, Shi-Wei;Chang, Yih-Leong;Chen, Ching-Chow; Lin, Y.-C. and Lin, Y.-C. and Shih, J.-Y. and Huang, W.-J. and Chao, S.-W. and Chang, Y.-L. and Chen, C.-C.; 張逸良;施金元;陳青周; YIH-LEONG CHANG; Lin, Yun-Chieh; JIN-YUAN SHIH; Lin, Yu-Chin; Shih, Jin-Yuan; Huang, Wei-Jan; Chao, Shi-Wei; Chang, Yih-Leong; Chen, Ching-Chow
臺大學術典藏 2020-03-06T05:26:13Z DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers Lin Y.-C.; Lin Y.-C.; Shih J.-Y.; Huang W.-J.; Chao S.-W.; YIH-LEONG CHANG; Chen C.-C.
臺大學術典藏 2020-03-07T06:56:23Z DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers Lin Y.-C.;Lin Y.-C.;Shih J.-Y.;Huang W.-J.;Chao S.-W.;Yih-Leong Chang;Chen C.-C.; Lin Y.-C.; Lin Y.-C.; Shih J.-Y.; Huang W.-J.; Chao S.-W.; YIH-LEONG CHANG; Chen C.-C.
臺大學術典藏 2020-08-13T06:33:43Z DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers Lin Y.-C.; Lin Y.-C.; JIN-YUAN SHIH; Huang W.-J.; Chao S.-W.; Chang Y.-L.; Chen C.-C.
臺大學術典藏 2021-05-07T05:13:26Z DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers Lin Y.-C.; Lin Y.-C.; Shih J.-Y.; Huang W.-J.; Chao S.-W.; Chang Y.-L.; CHING-CHOW CHEN

Showing items 346016-346040 of 2348609  (93945 Page(s) Totally)
<< < 13836 13837 13838 13839 13840 13841 13842 13843 13844 13845 > >>
View [10|25|50] records per page